{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:06:05Z","timestamp":1792667165823,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA258386"],"award-info":[{"award-number":["R01CA258386"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL137793"],"award-info":[{"award-number":["R01HL137793"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007268","name":"Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014571","name":"Alvin J. Siteman Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["BM200111"],"award-info":[{"award-number":["BM200111"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015570","name":"Blood Cancer UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015570","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.molmed.2022.08.001","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:33:56Z","timestamp":1661992436000},"page":"882-891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Telomere biology disorders: time for moving towards the clinic?"],"prefix":"10.1016","volume":"28","author":[{"given":"Luis F.Z.","family":"Batista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inderjeet","family":"Dokal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8412-4152","authenticated-orcid":false,"given":"Roy","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2022.08.001_bb0005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.genet.41.110306.130350","article-title":"How shelterin protects mammalian telomeres","volume":"42","author":"Palm","year":"2008","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.molmed.2022.08.001_bb0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1098\/rstb.2003.1370","article-title":"Telomeres and telomerase","volume":"359","author":"Chan","year":"2004","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.molmed.2022.08.001_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41580-021-00328-y","article-title":"Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization","volume":"22","author":"Lim","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0020","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrm.2016.43","article-title":"Stop pulling my strings - what telomeres taught us about the DNA damage response","volume":"17","author":"Lazzerini-Denchi","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/bies.202100157","article-title":"Challenging endings: how telomeres prevent fragility","volume":"43","author":"Glousker","year":"2021","journal-title":"Bioessays"},{"key":"10.1016\/j.molmed.2022.08.001_bb0030","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1101\/gad.263863.115","article-title":"Human telomerase: biogenesis, trafficking, recruitment, and activation","volume":"29","author":"Schmidt","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2022.08.001_bb0035","doi-asserted-by":"crossref","unstructured":"Nakamura, T.M., et al., Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955\u2013959","DOI":"10.1126\/science.277.5328.955"},{"key":"10.1016\/j.molmed.2022.08.001_bb0040","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/s42255-021-00483-8","article-title":"The metabolic roots of senescence: mechanisms and opportunities for intervention","volume":"3","author":"Wiley","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.molmed.2022.08.001_bb0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003558","article-title":"Telomerase: an RNP enzyme synthesizes DNA","volume":"3","author":"Blackburn","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0050","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41580-020-0234-z","article-title":"Regulation of human telomerase in homeostasis and disease","volume":"21","author":"Roake","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0055","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.diff.2018.01.004","article-title":"How stem cells keep telomeres in check","volume":"100","author":"Li","year":"2018","journal-title":"Differentiation"},{"key":"10.1016\/j.molmed.2022.08.001_bb0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.stem.2019.07.002","article-title":"Defining adult stem cell function at its simplest: the ability to replace lost cells through mitosis","volume":"25","author":"Post","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2022.08.001_bb0065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.gde.2013.07.006","article-title":"Understanding telomere diseases through analysis of patient-derived iPS cells","volume":"23","author":"Batista","year":"2013","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.molmed.2022.08.001_bb0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.tcb.2021.12.007","article-title":"Stem cells at odds with telomere maintenance and protection","volume":"32","author":"Penev","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0075","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.molcel.2021.03.033","article-title":"Alternative splicing is a developmental switch for hTERT expression","volume":"81","author":"Penev","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2022.08.001_bb0080","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.molmed.2022.08.001_bb0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.12688\/f1000research.14068.1","article-title":"Beginning at the ends: telomeres and human disease","volume":"7","author":"Savage","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.molmed.2022.08.001_bb0090","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bbadis.2009.01.010","article-title":"Dyskeratosis congenita, stem cells and telomeres","volume":"1792","author":"Kirwan","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.molmed.2022.08.001_bb0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng0598-32","article-title":"X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions","volume":"19","author":"Heiss","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2022.08.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.014017","article-title":"Molecular mechanisms of telomere biology disorders","volume":"296","author":"Grill","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2022.08.001_bb0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1242\/dmm.025130","article-title":"Telomeres in aging and disease: lessons from zebrafish","volume":"9","author":"Carneiro","year":"2016","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.molmed.2022.08.001_bb0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/33345","article-title":"Essential role of mouse telomerase in highly proliferative organs","volume":"392","author":"Lee","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.08.001_bb0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature09603","article-title":"Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice","volume":"469","author":"Jaskelioff","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.08.001_bb0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence","volume":"426","author":"d'Adda di Fagagna","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.08.001_bb0125","doi-asserted-by":"crossref","first-page":"10173","DOI":"10.1073\/pnas.0803559105","article-title":"A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice","volume":"105","author":"Gu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molmed.2022.08.001_bb0130","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.2011.08679.x","article-title":"Dyskeratosis congenita and the DNA damage response","volume":"153","author":"Kirwan","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.stemcr.2017.06.015","article-title":"p53 Mediates failure of human definitive hematopoiesis in dyskeratosis congenita","volume":"9","author":"Fok","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.molmed.2022.08.001_bb0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/ng1346","article-title":"Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC","volume":"36","author":"Vulliamy","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2022.08.001_bb0145","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/17474086.2019.1662720","article-title":"An update on the biology and management of dyskeratosis congenita and related telomere biology disorders","volume":"12","author":"Niewisch","year":"2019","journal-title":"Expert. Rev. Hematol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0150","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/15476286.2015.1094596","article-title":"The molecular genetics of the telomere biology disorders","volume":"13","author":"Bertuch","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mrfmmm.2011.10.013","article-title":"Telomerase and idiopathic pulmonary fibrosis","volume":"730","author":"Armanios","year":"2012","journal-title":"Mutat. Res."},{"key":"10.1016\/j.molmed.2022.08.001_bb0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.gde.2020.02.019","article-title":"Cancer and myeloid clonal evolution in the short telomere syndromes","volume":"60","author":"Schratz","year":"2020","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.molmed.2022.08.001_bb0165","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.mayocp.2018.03.020","article-title":"Short telomere syndromes in clinical practice: bridging bench and bedside","volume":"93","author":"Mangaonkar","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.molmed.2022.08.001_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101282","article-title":"Treatment of telomeropathies","volume":"34","author":"Vieri","year":"2021","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0175","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.hoc.2018.04.003","article-title":"Evaluation and management of hematopoietic failure in dyskeratosis congenita","volume":"32","author":"Agarwal","year":"2018","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.molmed.2022.08.001_bb0180","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1532\/IJH97.06030","article-title":"Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita","volume":"83","author":"Al-Rahawan","year":"2006","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0185","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1160\/TH12-02-0121","article-title":"Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and Diamond\u2013Blackfan anaemia","volume":"108","author":"Trautmann","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.molmed.2022.08.001_bb0190","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMc1607752","article-title":"Danazol treatment for telomere diseases","volume":"375","author":"Townsley","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.molmed.2022.08.001_bb0195","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1182\/bloodadvances.2018016964","article-title":"Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita","volume":"2","author":"Khincha","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.molmed.2022.08.001_bb0200","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2016.03.001","article-title":"Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature","volume":"22","author":"Barbaro","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.molmed.2022.08.001_bb0205","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1128\/MCB.19.1.567","article-title":"A box H\/ACA small nucleolar RNA-like domain at the human telomerase RNA 3\u2032 end","volume":"19","author":"Mitchell","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1101\/sqb.2006.71.025","article-title":"Biogenesis and intranuclear trafficking of human box C\/D and H\/ACA RNPs","volume":"71","author":"Kiss","year":"2006","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0215","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/15476286.2020.1809196","article-title":"Regulation of human telomerase RNA biogenesis and localization","volume":"18","author":"Qin","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/genes7090064","article-title":"Telomerase regulation from beginning to the end","volume":"7","author":"MacNeil","year":"2016","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.molmed.2022.08.001_bb0225","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1093\/nar\/gkz233","article-title":"N-terminal residues of human dyskerin are required for interactions with telomerase RNA that prevent RNA degradation","volume":"47","author":"MacNeil","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2022.08.001_bb0230","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1101\/gad.1476206","article-title":"Telomerase RNA level limits telomere maintenance in X-linked dyskeratosis congenita","volume":"20","author":"Wong","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2022.08.001_bb0235","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature10084","article-title":"Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells","volume":"474","author":"Batista","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.08.001_bb0240","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.7544491","article-title":"The RNA component of human telomerase","volume":"269","author":"Feng","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.molmed.2022.08.001_bb0245","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.molcel.2019.02.033","article-title":"Disruption of telomerase RNA maturation kinetics precipitates disease","volume":"74","author":"Roake","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2022.08.001_bb0250","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nsmb.3184","article-title":"Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects","volume":"23","author":"Shukla","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0255","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/ng.3423","article-title":"Poly(A)-specific ribonuclease (PARN) mediates 3\u2032-end maturation of the telomerase RNA component","volume":"47","author":"Moon","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2022.08.001_bb0260","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1038\/s41467-018-07822-6","article-title":"The H\/ACA complex disrupts triplex in hTR precursor to permit processing by RRP6 and PARN","volume":"9","author":"Tseng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.08.001_bb0265","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.celrep.2015.10.075","article-title":"Human telomerase RNA processing and quality control","volume":"13","author":"Tseng","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2022.08.001_bb0270","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/jmedgenet-2015-103292","article-title":"Bone marrow failure and developmental delay caused by mutations in poly(A)-specific ribonuclease (PARN)","volume":"52","author":"Dhanraj","year":"2015","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.molmed.2022.08.001_bb0275","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/ng.3278","article-title":"Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening","volume":"47","author":"Stuart","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molmed.2022.08.001_bb0280","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1172\/JCI78963","article-title":"Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita","volume":"125","author":"Tummala","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2022.08.001_bb0285","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1101\/gad.326785.119","article-title":"ZCCHC8, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation","volume":"33","author":"Gable","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2022.08.001_bb0290","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1172\/JCI87547","article-title":"Posttranscriptional manipulation of TERC reverses molecular hallmarks of telomere disease","volume":"126","author":"Boyraz","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2022.08.001_bb0295","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2018-11-885368","article-title":"Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita","volume":"133","author":"Fok","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.molmed.2022.08.001_bb0300","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.30329","article-title":"PAPD5\/7 are host factors that are required for hepatitis B virus RNA stabilization","volume":"69","author":"Mueller","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2022.08.001_bb0305","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2017.10.014","article-title":"A novel orally available small molecule that inhibits hepatitis B virus expression","volume":"68","author":"Mueller","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.molmed.2022.08.001_bb0310","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/bloodadvances.2020001848","article-title":"Chemical inhibition of PAPD5\/7 rescues telomerase function and hematopoiesis in dyskeratosis congenita","volume":"4","author":"Shukla","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.molmed.2022.08.001_bb0315","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.stem.2020.03.016","article-title":"Small-molecule PAPD5 inhibitors restore telomerase activity in patient stem cells","volume":"26","author":"Nagpal","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.molmed.2022.08.001_bb0320","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature10924","article-title":"Telomerase RNA biogenesis involves sequential binding by Sm and Lsm complexes","volume":"484","author":"Tang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2022.08.001_bb0325","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.celrep.2020.01.004","article-title":"Loss of human TGS1 hypermethylase promotes increased telomerase RNA and telomere elongation","volume":"30","author":"Chen","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.molmed.2022.08.001_bb0330","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1038\/s41467-022-29907-z","article-title":"TGS1 mediates 2,2,7-trimethyl guanosine capping of the human telomerase RNA to direct telomerase dependent telomere maintenance","volume":"13","author":"Buemi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2022.08.001_bb0335","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1873-3468.14240","article-title":"The S-adenosylmethionine analog sinefungin inhibits the trimethylguanosine synthase TGS1 to promote telomerase activity and telomere lengthening","volume":"596","author":"Galati","year":"2022","journal-title":"FEBS Lett."},{"key":"10.1016\/j.molmed.2022.08.001_bb0340","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41588-021-00944-6","article-title":"Polygenic basis and biomedical consequences of telomere length variation","volume":"53","author":"Codd","year":"2021","journal-title":"Nat. Genet."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491422002027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471491422002027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:25:18Z","timestamp":1761463518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471491422002027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1471491422002027"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2022.08.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Telomere biology disorders: time for moving towards the clinic?","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2022.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}